Application of Stem Cell Technology for Coronary Artery Disease at the All India Institute of Medical Sciences, New Delhi, India
DOI:
https://doi.org/10.1532/HSF98.20070701Abstract
Stem cell technology is rapidly gaining popularity as a way to improve the prognosis of patients with coronary artery disease and heart failure. In this review, we systematically analyze the basis, methods, and results of stem cell technology for coronary artery disease at the All India Institute of Medical Sciences, New Delhi, India.References
Blau HM, Brazelton TR, Weimann JM. 2001. The evolving concept of a stem cell: entity or function? Cell 105:829-41.nErtl G, Gaudron P, Hu K. 1993. Ventricular remodeling after myocardial infarction: experimental and clinical studies. Basic Res Cardiol 88:125-37.nGoodell MA, Jackson KA, Majka SM, et al. 2001. Stem cell plasticity in muscle and bone marrow. Ann N Y Acad Sci 938:208-18.nKrause DS, Theise ND, Collector MI, et al. 2001. Multi-organ, multilineage engraftment by a single bone marrow-derived stem cell. Cell 105:369-77.nLunde K, Solheim S, Aakhus S. 2006. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. New Engl J Med 355;1199-209.nOrlic D, Kajstura J, Chimenti S, et al. 2001. Bone marrow cells regenerate infarcted myocardium. Nature 410:701-5.nOrlic D, Kajstura J, Chimenti S, et al. 2001. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 98:10344-9.nPerin EC, Silva GC. 2004. Stem cell therapy for cardiac diseases. Curr Opin Hematol 11:399-403.nQuaini F, Urbanek K, Beltrami AP, et al. 2002. Chimerism of the transplanted heart. N Engl J Med 346:5-15.nRamakrishnan S, Kothari SS, Bahl VK. 2003. Stem cells and myocardial regeneration. Indian Heart J 55:119-24.nStrauer BE, Brehm M, Zeus T. 2002. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106:1913-8.nTomita S, Mickle DA, Weisel RD, et al. 2002. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg 123:1132-5.n
